NCT01967329 - CANHelp Working Group Treatment Trials | Biotech Hunter

Enrollment

338

Participants

Timeline

Start Date

November 30, 2008

Primary Completion Date

May 31, 2019

Study Completion Date

May 31, 2019

Conditions

Helicobacter Pylori Infection

Interventions

DRUG

Standard Triple

Oral twice-daily doses of rabeprazole (20 mg), amoxicillin (1 g) and clarithromycin (500 mg)

DRUG

Sequential

Oral twice-daily doses of rabeprazole (20 mg) and amoxicillin (1 g) on days 1-5, and on days 6-10, rabeprazole (20 mg), metronidazole (500 mg) and clarithromycin (500 mg)

DRUG

Quadruple

Oral doses of rabeprazole (20 mg) twice daily, metronidazole (500 mg) three times daily, bismuth subsalicylate (Pepto-Bismol) (2 tablets) four times daily and tetracycline (500 mg) four times daily

Trial Locations (1)

T6G 2E1

University of Alberta, Edmonton